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from Mycoplasma mycoides subsp. mycoides 
possesses anti-inflammatory properties
Philippe Totté1,2*, Carinne Puech1,2, Valérie Rodrigues1,2, Clothilde Bertin1,2, Lucia Manso‑Silvan1,2 
and François Thiaucourt1,2
Abstract 
In this study we explored the immunomodulatory properties of highly purified free galactan, the soluble exopoly‑
saccharide secreted by Mycoplasma mycoides subsp. mycoides (Mmm). Galactan was shown to bind to TLR2 but not 
TLR4 using HEK293 reporter cells and to induce the production of the anti‑inflammatory cytokine IL‑10 in bovine 
macrophages, whereas low IL‑12p40 and no TNF‑α, both pro‑inflammatory cytokines, were induced in these cells. 
In addition, pre‑treatment of macrophages with galactan substantially reduced lipopolysaccharide (LPS)‑induced 
production of pro‑inflammatory cytokines TNF‑ and IL‑12p40 while increasing LPS‑induced secretion of immunosup‑
pressive IL‑10. Also, galactan did not activate naïve lymphocytes and induced only low production of the Th1 cytokine 
IFN‑γ in Mmm‑experienced lymphocytes. Finally, galactan triggered weak recall proliferation of CD4+ T lymphocytes 
from contagious bovine pleuropneumonia‑infected animals despite having a positive effect on the expression of 
co‑stimulatory molecules on macrophages. All together, these results suggest that galactan possesses anti‑inflamma‑
tory properties and potentially provides Mmm with a mechanism to evade host innate and adaptive cell‑mediated 
immune responses.
© 2015 Totté et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Contagious bovine pleuropneumonia (CBPP) is a con-
tagious respiratory disease caused by Mycoplasma 
mycoides subsp. mycoides small colony biotype (Mmm) 
and notifiable to the World Organization for Animal 
Health [1]. Respiratory distress occurs in acute forms 
of CBPP frequently followed by death in the absence of 
antibiotic treatment. Lesions in the thoracic cavity are 
suggestive of an overwhelming inflammatory response 
developed by the host. The prominent lesions in the lung 
include: thrombosis of lymphatics and blood vessels; 
interlobular edema; hepatisation and consolidation of 
individual lobules leading to a marbled appearance of the 
lung, and yellow or turbid exudates in the pleural cavity 
(reviewed in [2]). In addition, archetypal inflammatory 
cytokines are detected in  vitro in supernatants of mac-
rophages stimulated with several Mmm strains and 
in vivo in the plasma of cattle during the course of experi-
mental infection with virulent Mmm [3, 4].
The mechanisms and components of Mmm involved in 
immunomodulation in general and in host inflammatory 
responses in particular are poorly characterized. Avail-
able Mmm sequenced genomes [5, 6] indicate that clas-
sical virulence determinants such as toxins, invasins or 
cytolysins, are absent in Mmm. More probably, the vir-
ulence factors of mycoplasma species seem to be deter-
mined by intrinsic metabolic pathway functions [7, 8] or 
by constituents of the mycoplasmal outer surface includ-
ing lipoproteins and polysaccharides. Mmm cells secrete 
galactan, a homopolysaccharide consisting of β1  →  6 
galactofuranosyl sub-units and present as a capsular form 
(CPS) and as a free extracellular form hereafter termed 
exopolysaccharide (EPS) [9, 10]. While CPS and EPS pos-
sess the same type of homopolysaccharide, the former 
differs from the latter as it is linked to a lipid anchored 
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moiety, probably a diglycosyldiacylglycerol residue as for 
Mycoplasma genitalium [11]. The physical and biological 
properties of CPS and EPS may therefore vary consider-
ably. Galactan EPS is secreted in high quantities by Mmm 
that multiply in the lung lesions and, because it is solu-
ble, it is found in large amounts in the blood of infected 
cattle [12]. Biological effects of crude galactan observed 
after intravenous injection in cattle include: increased 
pulmonary arterial and decreased systemic arterial blood 
pressures, hemorrhages associated with alveolar ducts 
and vessel walls, areas of pulmonary edema, induced 
lesions in joints and kidneys and a prolonged mycoplas-
maemia after subcutaneous injection of live Mmm [13, 
14]. These results suggest a possible role for galactan as 
a pro-inflammatory factor although the contribution of 
contaminating components such as polypeptides and 
non-Mmm polysaccharides present in the enriched cul-
ture medium cannot be excluded. Recently, we reported 
a method using a chemically defined synthetic medium 
to maintain Mmm viability and allow the preparation of 
free galactan EPS of high purity as shown by silver stain-
ing on SDS-PAGE and nuclear magnetic resonance spec-
troscopy [10].
Macrophages express a large repertoire of pathogen-
recognition receptors, including toll-like receptors 
(TLRs), and are key players in the initiation of inflamma-
tory responses during infection [15]. Inflammation is a 
highly complex response under the control of a network 
of cytokines with either pro-inflammatory effects such 
as IL-1β, IL-12p40, TNF-α, IFN-γ, or anti-inflammatory 
properties such as IL-10 and TGF-β (reviewed in [16]). 
Bacterial polysaccharides are capable of inducing the pro-
duction of pro-inflammatory cytokines by macrophages 
through interaction with TLR2 and/or TLR4 [17–21]. In 
addition, lymphocytes of the Th1 subset may also trig-
ger or exacerbate inflammation as a result of interactions 
with bacterial polysaccharides through a mechanism 
depending on both TLR2 and antigen presentation [18, 
22]. Importantly, antigen presentation to lymphocytes by 
antigen presenting cells (APC) such as dendritic cells and 
macrophages requires expression of co-stimulatory mol-
ecules including CD40, CD80, and CD86 [23].
In an effort to address the pathogenesis of CBPP, we 
investigated the interactions of highly purified galactan 
EPS, the free exopolysaccharide of Mmm, with bovine 
cells involved in both innate and acquired immunity. First 
of all, binding of galactan to TLRs was analyzed using 
highly sensitive transformed cell lines. Then, the effects 
of galactan on cytokines production and expression of 
co-stimulatory molecules by bovine macrophages were 
characterized. Finally, the capacity of galactan to trigger 
a pro-inflammatory Th1-like response from lymphocytes 
of naïve and CBPP-infected animals was investigated.
Materials and methods
Ethics statement
The use of cattle as a source of macrophages and lympho-
cytes was approved by the Languedoc-Roussillon Animal 
Ethics Committee (CEEA-LR No. 36) and carried out in 
strict accordance with the French Ministry of Agricul-
ture’s guidelines for use of animals for scientific purposes.
Preparation of galactan and whole antigen from Mmm
Mmm strains Afadé and T1/44 were used for galactan 
purification and stimulation of lymphocytes respectively. 
For the preparation of highly pure galactan EPS, Mmm 
Afadé was first grown in PPLO-based medium before 
transfer in chemically defined CMRL-1066 medium 
(Invitrogen, France) in which de novo synthesis of poly-
saccharides was previously shown [10]. To purify the 
galactan EPS, cells were removed by centrifugation and 
polypeptides were precipitated from the supernatant 
with 1/10 volume of cold 100% (w/v) trichloroacetic acid 
(Sigma-Aldrich) at 4 °C for 2 h followed by centrifugation 
(14 000 g, 60 min, 4 °C). Polysaccharides contained in the 
supernatant were precipitated with 6–10 volumes of cold 
acetone at −20 °C for 48 h and collected after centrifuga-
tion (14 000 g, 60 min, 4  °C). The acetone was carefully 
removed and the pellet was air-dried and dissolved in 
ultra-pure sterile water and dialyzed in 3.5  kDa cut-off 
dialysis tubing (Spectrum Laboratories) to remove small 
peptides. Galactan concentration was estimated by the 
phenol/sulfuric acid method using glucose as standard 
and stored at 4 °C until used [10].
Killed Mmm were also prepared from log phase T1/44 
cultures grown in PPLO and washed two times in PBS 
before protein titration by the bicinchoninic acid method. 
The T1/44 strain of Mmm was chosen as a positive con-
trol of antigen-specific proliferation as shown in previous 
work [24]. Mmm organisms had to be inactivated before 
use in co-cultures with lymphocytes to avoid direct kill-
ing of cells [25]. Whole inactivated Mmm antigen was 
obtained after heating at 60 °C for 1 h and was stored at 
−20 °C until used.
Macrophages and cell lines expressing TLRs
For macrophages, heparinized blood was collected from 
the jugular vein of healthy cattle and peripheral blood 
mononuclear cells (PBMC) were purified using standard 
procedures. Monocytes were separated from other cells 
by positive selection of CD14+ cells using anti-human 
CD14 magnetic microbeads (Miltenyi Biotec GmbH, 
Germany) according to the manufacturer’s instructions 
and resuspended in Iscove’s modified Dulbecco’s medium 
(IMDM) supplemented with 2  mM l-glutamine, 50  μM 
2-mercaptoethanol, 50 µg/mL gentamycin (Life Technol-
ogies, France) and 10% heat inactivated fetal calf serum 
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(FCS; Eurobio AbCys, France). CD14+ cells were seeded 
at 1 ×  106  cells/mL in 24-well plates and incubated for 
5 days at 37 °C and 5% CO2. For stimulation assays, mac-
rophages were incubated for 48 h at 37  °C and 5% CO2 
with different concentrations of galactan or 2  μg/mL of 
lipopolysaccharide (LPS) from Escherichia coli 0111:B4 
(Invivogen, France) as a positive control. Supernatants 
were centrifuged at 300 × g to remove cells before stor-
age at −20 °C.
HEK-Blue™ mTLR2 (HEK-TLR2) and HEK-Blue™ 
mTLR4 (HEK-TLR4) cell lines (Invivogen, France) are 
derivative of HEK293 cells obtained respectively by co-
transfection of the mouse TLR2 or TLR4 and secreted 
embryonic alkaline phosphatase (SEAP) genes. Ligand 
activation of TLR induces production of SEAP and 
QUANTI-Blue™ (Invivogen, France), a colorimetric 
enzyme assay, allows quantification of SEAP in super-
natants using a spectrophotometer at 620-655  nm. 
HEK-Blue™ Null1 (HEK-Null1) and HEK-Blue™ Null2 
(HEK-Null2) cell lines (Invivogen, France) are parental 
cell lines transfected only with the SEAP gene. For stimu-
lation assays, cells were seeded in 96-wells plates in rec-
ommended media (Invivogen, France) and incubated for 
20 h at 37 °C and 5% CO2 with different concentrations of 
EPS, and with specific TLR agonists (Invivogen, France): 
100  ng/mL of synthetic diacylated lipoprotein (FSL1) 
for TLR2, and 10  ng/mL of LPS from E. coli 0111:B4 
for TLR4. Supernatants were titrated for alkaline phos-
phatase activity in duplicates.
Lymphoproliferative assays
Cells were prepared from mediastinal lymph nodes 
draining the lungs of naïve and CBPP-infected cattle (also 
called Mmm-experienced cells) and stored in liquid nitro-
gen as previously described [26]. Upon thawing, cells 
were loaded with carboxyfluorescein diacetate succinimi-
dyl ester (CFSE, Invitrogen, France) at a final concentra-
tion of 1 μM before incubation for 7 days with 5 μg/mL 
of heat-inactivated Mmm or 2.5  μg/mL of the mitogen 
Concanavalin A (ConA) as a positive control. Cells from 
CBPP-infected and naïve animals showed similar reac-
tivity to ConA and only assays in which ConA controls 
were within an acceptable range were analyzed further. 
Galactan was used at a final concentration of 10 μg/mL 
unless specified otherwise. Finally, purified protein deriv-
ative from Mycobacterium avium subsp. paratuberculosis 
(PPDa) cultures (Prionics AG, Switzerland) was used as 
irrelevant antigen to measure non-specific proliferation.
Flow cytometry
Lymph node cells were surface stained with the follow-
ing primary monoclonal antibodies (mAb): mAb IL-A11 
(IgG2a) for CD4 (VMRD, USA). Macrophages were 
stained with mAb IL-A156 for CD40, and mAb IL-A159 
for CD80 (all IgG1 isotype from AbD Serotec, UK). Cells 
were then washed and stained with fluorochrome-con-
jugated, isotype-specific antibodies. Debris and dead 
cells were excluded from analysis based on granular-
ity and size and, for lymphocytes, based on inclusion 
of 7-amino-actinomycin D (7-AAD) as a viability dye 
(BD Biosciences, USA). Multiple color analyses were 
performed with a flow cytometer (FACScanto; Becton–
Dickinson) equipped with the FACSDiva software (BD 
Biosciences) after the acquisition of at least 5000 events. 
Control isotype antibodies (AbD Serotec, UK) were used 
to evaluate nonspecific binding and to set gates and 
quadrants delineating positive populations. Results were 
expressed as percentages of positively labeled cells and/
or geometric mean fluorescence intensity (MFI). Prolif-
eration levels were expressed as percentages of CFSElow 
cells which correspond to decreased CFSE fluorescence 
intensity relative to that in undivided cells.
Cytokines ELISA
For bovine IFN-γ, the Bovigam™ ELISA kit (Prionics AG, 
Switzerland) was used according to the manufacturer’s 
instructions and results are expressed as mean optical 
densities of duplicate assays. For bovine IL-10, IL-12p40, 
and TNF-α, matched antibody pairs (AbD Serotec, UK) 
were used in sandwich ELISA as described previously 
[27] with minor modifications. Briefly, 96 wells NUNC 
MaxiSorp™ plates (Thermo Fisher Scientific, Germany) 
were coated with capture antibodies and washed after 
blocking. After incubating the plates with culture super-
natants in duplicates, and washing, specific detection 
antibodies coupled to biotin were added. Serial dilutions 
of recombinant bovine cytokines were used to gener-
ate a calibration curve. After washing, the plates were 
incubated with streptavidin coupled to horseradish per-
oxidase (Sigma-Aldrich, France) and washed before add-
ing a solution containing tetramethylbenzidine (TMB). 
The reaction was blocked with H2SO4 at 1 M and plates 
were read at 450 nm using an ELISA reader. Results are 
expressed as mean protein concentrations.
Statistics
A nonparametric Mann–Whitney U-test [28] was used 
to analyze differences between responses obtained with 
various stimuli. A difference was considered to be signifi-
cant at a p value of <0.05.
Results
Galactan is recognized by TLR2 but not TLR4
The level of SEAP protein released into the culture media 
by TLR-transfected HEK cells was used to quantify the 
extent of TLR2 or TLR4 stimulation which also correlates 
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with the level of NF-κB activation. As shown in Figure 1, 
galactan triggered a significant release of SEAP protein 
by HEK cells expressing TLR2. The activity of galactan 
was detected even at the lowest concentration and was 
dose dependent. In contrast, no activity of galactan was 
detected with null-cells or with cells expressing TLR4.
Galactan induces an anti‑inflammatory cytokine response 
in bovine macrophages and inhibits the pro‑inflammatory 
activity of LPS
As shown in Figure  2, TNF-α was not produced by 
macrophages in response to galactan and low levels of 
IL-12p40 were detected but only at the highest con-
centration used. This was not due to an intrinsic lack of 
response by macrophages as shown by a substantial pro-
duction in the presence of LPS. In contrast, a significant 
induction of IL-10 was detected after stimulation with 
1 μg/mL of galactan. The production of IL-10 in response 
to galactan was dose-dependent as 10 µg/mL induced a 
substantially higher response.
When macrophages were treated with galactan prior 
to LPS stimulation, TNF-α and IL-12p40 responses 
triggered by LPS were reduced by 55 ±  9 and 88 ±  3% 
respectively (Figure  3). On the other hand, the produc-
tion of IL-10 significantly increased although with a high 
amplitude in the effect of galactan between different 
experiments (i.e., from 130 to 300% as shown in Figure 3).
Cell‑surface expression of co‑stimulatory molecules 
on bovine macrophages is increased by galactan
Although around 80% of macrophages constitutively 
expressed CD40 (Figure 4A), the proportion of positive 
cells reached 100% of the total population in the pres-
ence of galactan. The positive effect of galactan on CD40 
expression was confirmed by a substantial increase in 
the mean fluorescence intensity (MFI) which is an esti-
mation of the mean number of CD40 molecules per 
cell (Additional file  1). In addition, cell surface expres-
sion of CD80 was strongly induced by galactan with 
up to a fourfold increase observed at the highest dose 
(Figure 4B).
Figure 1 Effect of free Mmm galactan on secreted embryonic 
alkaline phosphatase (SEAP) release from HEK-Blue mTLR2 
cells (A) and HEK-Blue mTLR4 cells (B). Null‑cells (i.e., HEK‑Blue 
cells neither expressing TLR2 nor TLR4) or TLR‑cells were incubated 
with galactan (EPS) at 0.1, 1 and 10 µg/mL, or with FSL1 lipopeptide 
and E. coli LPS as positive controls for TLR2 and TLR4 cells respec‑
tively. SEAP release after stimulation was measured by a colorimetric 
method and expressed as mean fold changes (±SD) in comparison 
to unstimulated cells (n = 3). *p < 0.001 relative to unstimulated 
controls; **p < 0.05 between different EPS concentrations.
Figure 2 Effect of free Mmm galactan on TNF-α (A), IL-12p40 
(B), and IL-10 (C) release by bovine macrophages. Cells were 
incubated for 48 h with galactan (EPS) at 0.1, 1 and 10 µg/mL, or with 
E. coli LPS and medium only as positive and negative (C−) controls 
respectively. Estimation of cytokine production was performed by 
ELISA. Results are expressed as mean (±SD) protein concentrations of 
three different experiments. Asterisks indicate statistically significant 
differences (p < 0.05) with the negative control.
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CD4+ T cells from CBPP‑infected cattle but not naïve 
animals proliferate in response to galactan and produce 
low levels of IFN‑γ
As Th1 cells belong to the CD4+ lineage of T lympho-
cytes, we focused on that particular sub-population. No 
proliferation was detected upon in  vitro stimulation of 
CFSE-labeled CD4+ T cells from naïve animals with 
Mmm galactan (Figure  5A). On the other hand, Mmm-
experienced CD4+ T cells proliferated in response to both 
galactan and whole inactivated Mmm in a specific manner 
as demonstrated by a statistically significant higher per-
centage of proliferation in comparison to irrelevant PPDa 
antigen (Figure 5B). Finally, analysis of lymphocytes other 
than CD4 (i.e., the CD4− population comprising B cells, 
CD8+ and γδTCR+ T cells) revealed a significant pro-
liferation but exclusively in cultures that were stimulated 
with whole inactivated Mmm (Additional file 2).
The secretion of the Th1 cytokine IFN-γ was measured 
in cultures supernatants. As observed for proliferation, 
specific recall IFN-γ responses were detected only when 
cells from CBPP-infected cattle were used (Figures  6A 
and B). In these animals, galactan induced significant 
IFN-γ responses although at much lower levels than 
those obtained with inactivated Mmm (Figure  6B). 
Increasing the dose of galactan did not allow matching of 
IFN-γ responses obtained with inactivated Mmm despite 
comparable proliferation levels (Figure 6C).
Discussion
The Mmm polysaccharide, galactan, is highly immuno-
genic as shown by antibody responses detected during 
infection and characterized by a very rapid and high level 
of IgM directed towards polysaccharidic Mmm compo-
nents [12]. However, at the same time, Mmm that mul-
tiply in lung lesions are secreting free galactan EPS but 
there is no data available concerning the immunomodu-
latory properties of this compound. In this study, we 
investigated the impact of EPS on innate immunity 
through activation of bovine macrophages and naïve lym-
phocytes, and, on adaptive immunity, through expression 
of co-stimulatory molecules on macrophages and recall 
activation of Mmm-experienced lymphocytes.
The first step of this study was to identify a recep-
tor for galactan among TLRs given their essential role 
in the early recognition of bacterial infections by the 
host immune system. Galactan was shown to interact 
with TLR2 which was supporting evidence for a poten-
tial involvement in innate immunity through interaction 
with TLR2-expressing cells such as macrophages and T 
lymphocytes [29]. The high purity grade of the galactan 
preparation used in our study was shown previously by 
silver staining on SDS-PAGE and nuclear magnetic reso-
nance spectroscopy (NMR) [10]. However, as reported by 
Geurtsen et al. [35] for α-glucan purified from Mycobac-
terium tuberculosis, lipopeptides can be present at con-
centrations not detectable even by NMR and still induce 
substantial TLR2-dependent activity. In addition, the 
authors showed that these lipopeptides were success-
fully removed by phenol treatment [35]. In our model, 
we observed that reporter HEK cells could easily detect 
Figure 3 Effect of pre-treatment with free Mmm galactan on 
LPS-induced release of TNF-α (A), IL-12p40 (B), and IL-10 (C) by 
bovine macrophages. Cells were incubated with LPS alone at 2 µg/
mL (LPS), galactan alone at 10 µg/mL (EPS), or galactan for 8 h before 
stimulation with 2 µg/mL of LPS (EPS + LPS). ELISA was used to 
detect levels of secreted cytokines in 2‑day‑old supernatants. Results 
from three different experiments are expressed as mean (±SD) 
percentage of the value obtained with LPS alone. Asterisks indicate 
statistically significant differences (p < 0.05) between LPS alone and 
EPS + LPS.
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TLR2 activity triggered by FSL1, a lipopeptide produced 
by Mycoplasma salivarium, even at concentrations as low 
as 100  pg/mL (Additional file  3B). Therefore, we tested 
phenol treatment and showed that it did not significantly 
affect the TLR2 activity of galactan whereas it completely 
abrogated the activity of FSL1 (Additional file 3).
In contrast to TLR2-expressing HEK cells, we could 
not detect any activation of naïve lymphocytes by 
galactan as shown by the absence of cytokine release, 
proliferation, or even morphological changes (i.e., blas-
togenesis and cell death). Also, galactan had no meas-
urable effects on naïve CD4+ T lymphocytes and this 
was not due to cytotoxicity. On the other hand, inter-
action between galactan and bovine macrophages 
resulted in a substantial release of IL-10, whereas 
low IL-12p40 and no TNF-α, both pro-inflammatory 
cytokines, were induced in these cells. In addition, the 
anti-inflammatory activity of galactan was confirmed 
by its ability to counteract the activity of LPS, a potent 
mediator of inflammation. Indeed, pre-treatment of 
macrophages by galactan dramatically reduced TNF-α 
and IL-12p40 responses triggered by LPS but also sig-
nificantly increased (i.e., up to 300%) the production 
of IL-10. The lack of pro-inflammatory activity of cer-
tain polysaccharides and their capacity to inhibit LPS 
pro-inflammatory activity has been reported previously 
[30–34] and notably for another mycoplasmal EPS [30]. 
Moreover, α-glucan from Mycobacterium tuberculo-
sis is known to amplify the LPS-mediated production 
of IL-10 by dendritic cells [35]. However, a dual effect, 
as described here for Mmm galactan and consisting in 
the concomitant inhibition of LPS pro-inflammatory 
activity and amplification of LPS anti-inflammatory 
activity via IL-10, has not been reported for other 
Figure 4 Effect of free Mmm galactan on surface expression of CD40 (A) and CD80 (B) on bovine macrophages. Cells were incubated 
for 48 h with galactan (EPS) at 0.1, 1 and 10 µg/mL, or with LPS and medium only (C−) as positive and negative controls respectively. Cell‑surface 
expression of CD40/CD80 was measured by flow cytometry and results expressed as mean (±SD) percentages of positive cells for a given marker 
(n = 3). Asterisks indicate statistically significant differences (p < 0.05) with the negative control.
Figure 5 Effect of free Mmm galactan on recall proliferation of CD4+ T lymphocytes from naïve cattle (A) and CBPP-infected cattle 
(B). CFSE‑labeled cells were stimulated for 7 days with whole inactivated Mmm (T1/44, 5 μg/mL), galactan (EPS, 10 μg/mL) or PPDa (10 μg/mL). Dif‑
ferent symbols represent the net effect of stimulations (i.e., stimulated cultures minus non‑stimulated cultures) for each animal individually (n = 3). 
Asterisks indicate statistically significant differences with PPDa.
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polysaccharides to the best of our knowledge. The 
galactan-mediated reduction of LPS-induced TNF-α 
release by macrophages may be explained by IL-10 act-
ing on transcription factors such as STAT3 [36]. On the 
other hand, the amplification effect of galactan on LPS-
induced IL-10 is probably more complex. For example, 
certain lipoglycans and glycans from Mycobacterium 
tuberculosis induce both prolonged and increased IL10 
transcription in LPS-activated cells through interaction 
with C-type lectins rather than TLRs [35, 37]. Assess-
ing the precise contribution of TLRs and C-type lectins 
in our model will await availability of reagents appro-
priate for use with bovine cells. Importantly, as far as 
CBPP is concerned, lipoproteins rather than LPS are in 
the top list of putative pro-inflammatory Mmm mole-
cules [38]. Interestingly, IL-10 has also been shown to 
dampen the pro-inflammatory activity of lipoproteins 
[39, 40].
Galactan EPS from Mmm increased the expression 
of CD40 and CD80 co-stimulatory molecules on the 
surface of macrophages. In addition, galactan-specific 
recall proliferation of CD4+ T lymphocytes and IFN-γ 
responses were detected among lymphocytes draining 
the lungs of CBPP-infected cattle. However, cell medi-
ated immune responses against galactan differed from 
recall responses triggered by whole inactivated Mmm 
in several ways. First, only CD4+ T lymphocytes pro-
liferated in response to galactan whereas both CD4+ 
and CD4− T lymphocytes (most likely B lymphocytes 
as reported previously [25]) responded to Mmm. Sec-
ond, both proliferation and IFN-γ recall responses 
induced by galactan were significantly lower (p < 0.05) 
than those triggered by Mmm. Third, a high amount of 
galactan was needed to match Mmm-induced prolifera-
tion of CD4+ T lymphocytes but IFN-γ levels remained 
substantially lower. Thus, the galactan-specific CD4+ T 
lymphocytes elicited in these animals are relatively poor 
producers of the Th1 cytokine when compared to their 
Mmm-specific homologues. A more complete cytokine 
profiling, including Th2, Th17 and Th22 cytokines, 
may be required in order to better characterize these 
responses.
Figure 6 Effect of free Mmm galactan on recall IFN-γ responses from naïve cattle (A) and CBPP-infected cattle (B). Cells were stimulated 
for 7 days with whole inactivated Mmm (T1/44, 5 μg/mL), galactan (EPS, 10 μg/mL) or PPDa (10 μg/mL). Different symbols represent the net effect 
of stimulations (i.e., stimulated cultures minus non‑stimulated cultures) for each animal individually (n = 3). Asterisks indicate statistically significant 
differences with PPDa. C Dose effect of galactan (EPS) on CD4 proliferation and IFN‑γ responses.
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In summary, we have shown here that galactan EPS, 
the free soluble form of Mmm polysaccharide, possesses 
anti-inflammatory properties and induces the produc-
tion of IL-10 by macrophages. This result provides a 
likely explanation for the progressive increase in IL-10 
detected in the plasma of cattle undergoing experimen-
tal CBPP [4]. Moreover, large amount of galactan are 
found in the blood of animals undergoing acute CBPP 
[12] which is also consistent with higher levels of plasma 
IL-10 detected in these animals when compared to ani-
mals with chronic CBPP [4]. In addition to multiple 
inhibitory effects on innate immunity (e.g., inhibition of 
pro-inflammatory cytokine release by macrophages [41, 
42], and reduction of macrophage microbicidal activ-
ity [43]), IL-10 may also attenuate adaptative immunity 
by down-regulating the expression of IL-2 receptor on 
bovine T lymphocytes [44]. Thus, galactan may poten-
tially also depress T cell responses directed at Mmm pro-
teins. Interestingly, lower Mmm-induced recall activation 
of CD4+ T lymphocytes was detected in draining lymph 
nodes of animals chronically infected (i.e., presence of 
Mmm -containing sequestra in the lungs) in compari-
son to animals showing complete recovery [26]. Also, we 
have recently reported the absence of measurable T-cell 
responses in cattle one month after immunization with 
the attenuated T1/44 vaccine strain of Mmm [45]. The 
T1/44 strain also produces the EPS form of galactan [46] 
which may therefore potentially contribute to its poor 
T-cell immunogenicity.
All together our results suggest that free Mmm 
galactan, or EPS, is not involved in the inflammatory 
reaction which is the hallmark of acute CBPP. Thus, more 
work is needed to evaluate pro-inflammatory properties 
of other components of the Mmm membrane, including 
the CPS form of galactan and lipoproteins, as well as the 
Mmm secretome as a whole. In addition, our results sug-
gest that EPS may dampen the host innate and possibly 
also acquired cell-mediated immune responses through 
the production of immunosuppressive IL-10. The role 
of other well-known mediators of innate immunity such 
as chemokines, but also other immunocompetent cells 
such as NK cells and dendritic cells deserves in-depth 
investigation.
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